Download PDF
Horm Metab Res 2004; 36(1): 62-66
DOI: 10.1055/s-2004-814201
Original Clinical
© Georg Thieme Verlag Stuttgart · New York

Changes in Serum Testosterone and Estradiol Concentrations Following Acute Androstenedione Ingestion in Young Women

G.  A.  Brown1 , J.  C.  Dewey1 , J.  A.  Brunkhorst1 , M.  D.  Vukovich2 , D.  S.  King1
  • 1Exercise Biochemistry Laboratory, Department of Health and Human Performance, Iowa State University, Ames, IA
  • 2Human Performance Laboratory, South Dakota State University, Department of HPER, Brooking, SD
Present affiliation of Gregory A. Brown, PhD: Human Performance Laboratory, Dept. of Public Health, Georgia Southern University, Statesboro, GA
Further Information

Publication History

Received 29 October 2002

Accepted after revision 7 July 2003

Publication Date:
25 February 2004 (online)

Also available at
    Permissions and Reprints

Abstract

The effect of androstenedione intake on serum hormone concentrations in women is equivocal. Therefore, we examined the hormonal response to androstenedione intake in healthy young (22.1 ± 0.4 y) women for 4 hours. On day 3 of the follicular phase, subjects ingested placebo, 100, or 300 mg androstenedione in a random, double-blind, cross-over manner. Blood samples were collected before and every 30 min for 240 min after intake. Serum androstenedione concentrations (means ± SE) increased above basal (6.2 ± 0.8 nmol/l) from 60 - 240 min for both 100 mg (22.6 ± 1.0 nmol/l at 240 min) and 300 mg (28.1 ± 1.3 nmol/l at 210 min). Androstenedione intake increased serum total testosterone concentrations above basal (1.2 ± 0.2 nmol/l) from 120 - 240 min (5.5 ± 0.9 nmol/l at 210 min) with 100 mg and from 60 - 240 with 300 mg (10.2 ± 1.6 nmol/l at 210 min). Androstenedione intake also increased serum estradiol concentrations (basal 191 ± 24 pmol/l) at 150 min with 100 mg (237 ± 35 pmol/l) and from 150 - 240 min with 300 mg (reaching 260 ± 32 pmol/l at 240 min). These data indicate that, in contrast to men, androstenedione intake in women increases serum testosterone concentrations.

Key words

Androstenedion - Hormone response - Women

References

  • 1 Brown G A, Vukovich M D, Reifenrath T A, Uhl N L, Parsons K A, Sharp R L, King D S. Effects of anabolic precursors on serum testosterone concentrations and adaptations to resistance training in young men.  Int J Sport Nutr Exerc Metab. 2000;  10 340-359
    PubMedGoogle Scholar
  • 2 King D S, Sharp R L, Vukovich M D, Brown G A, Reifenrath T A, Uhl N L, Parsons K A. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial.  JAMA. 1999;  281 2020-2028
    CrossrefPubMedGoogle Scholar
  • 3 Earnest C P, Olson M A, Broeder C E, Breuel K F, Beckham S G. In vivo 4-androstene-3,17-dione and 4-androstene-3 beta,17 beta-diol supplementation in young men.  Eur J Appl Physiol. 2000;  81 229-232
    CrossrefPubMedGoogle Scholar
  • 4 Rasmussen B B, Volpi E, Gore D C, Wolfe R R. Androstenedione does not stimulate muscle protein anabolism in young healthy men.  J Clin Endocrinol Metab. 2000;  85 55-59
    CrossrefPubMedGoogle Scholar
  • 5 Leder B Z, Longcope C, Catlin D H, Ahrens B, Schoenfeld D A, Finkelstein J S. Oral androstenedione administration and serum testosterone concentrations in young men.  JAMA. 2000;  283 779-782
    CrossrefPubMedGoogle Scholar
  • 6 Ballantyne C S, Phillips S M, MacDonald J R, Tarnopolsky M A, MacDougall J D. The acute effects of androstenedione supplementation in healthy young males.  Can J Appl Physiol. 2000;  25 68-78
    PubMedGoogle Scholar
  • 7 Brown G A, Vukovich M D, Martini E R, Kohut M L, Franke W D, Jackson D A, King D S. Effects of androstenedione-herbal supplementation on serum sex hormone concentrations in 30- to 59-year-old men.  Int J Vitam Nutr Res. 2001;  71 293-301
    PubMedGoogle Scholar
  • 8 Brown G A, Vukovich M D, Martini E R, Kohut M L, Franke W D, Jackson D A, King D S. Endocrine responses to chronic androstenedione intake in 30- to 56-year- old men.  J Clin Endocrinol Metab. 2000;  85 4074-4080
    CrossrefPubMedGoogle Scholar
  • 9 Kanayama G, Gruber A J, Pope H G Jr, Borowiecki J J, Hudson J I. Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem?.  Psychother Psychosom. 2001;  70 137-140
    PubMedGoogle Scholar
  • 10 Labrie F, Luu-The V, Lin S X, Labrie C, Simard J, Breton R, Belanger A. The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology.  Steroids. 1997;  62 148-158
    CrossrefPubMedGoogle Scholar
  • 11 Mahesh V B, Greenblatt R B. The in vivo conversion of dehydroepiandrosterone and androstenedione to testosterone in the human.  Acta Endrocrinol. 1962;  41 400-406
    PubMedGoogle Scholar
  • 12 Kicman A T, Bassindale T, Cowan D A, Dale S, Hutt A J, Leeds A R. Effect of androstenedione ingestion on plasma testosterone in young women; a dietary supplement with potential health risks.  Clin Chem. 2003;  49 167-169
    PubMedGoogle Scholar
  • 13 Leder B Z, Leblanc K M, Longcope C, Lee H, Catlin D H, Finkelstein J S. Effects of oral androstenedione administration on serum testosterone and estradiol levels in postmenopausal women.  J Clin Endocrinol Metab. 2002;  87 5449-5454
    CrossrefPubMedGoogle Scholar
  • 14 Goldman H I, Becklake M R. Respiratory Function Tests.  Am Rev Tuberc Pulm Dis. 1959;  79 457-467
    PubMedGoogle Scholar
  • 15 Siri W E. Body composition from fluid spaces and density. In: Brozek JR, Henschel A (ed) Techniques for Measuring Body Composition. Washington, DC; National Academy of Sciences 1961: 223-244
    Google Scholar
  • 16 Wilson K. Sex-related differences in drug disposition in man.  Clin Pharmacokinet. 1984;  9 189-202
    PubMedGoogle Scholar
  • 17 Horton R, Tait J F. Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone.  J Clin Invest. 1966;  45 301-313
    PubMedGoogle Scholar
  • 18 Gray A, Feldman H A, McKinlay J B, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study.  J Clin Endocrinol Metab. 1991;  73 1016-1025
    PubMedGoogle Scholar
  • 19 Eiletz J, Genz T, Pollow K, Schmidt-Gollwitzer M. Sex steroid levels in serum, myometrium, and fibromyomata in correlation with cytoplasmic receptors and 17 beta-HSD activity in different age-groups and phases of the menstrual cycle.  Arch Gynecol. 1980;  229 13-28
    PubMedGoogle Scholar
  • 20 Lindberg M C, McClenaghan C, Herrmann W L. Fate of injected dehydroisoandrosterone, testosterone, and dehydroiisoandrosterone sulfate in plasma in the human.  Am J Obstet Gynecol. 1966;  95 743-746
    PubMedGoogle Scholar
  • 21 Mortola J F, Yen S S. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women.  J Clin Endocrinol Metab. 1990;  71 696-704
    PubMedGoogle Scholar
  • 22 Morales A J, Haubrich R H, Hwang J Y, Asakura H, Yen S S. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.  Clin Endocrinol (Oxf). 1998;  49 421-432
    CrossrefPubMedGoogle Scholar
  • 23 Morales A J, Nolan J J, Nelson J C, Yen S S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.  J Clin Endocrinol Metab. 1994;  78 1360-1367
    CrossrefPubMedGoogle Scholar
  • 24 Padero M C, Bhasin S, Friedman T C. Androgen supplementation in older women: too much hype, not enough data.  J Am Geriatr Soc. 2002;  50 1131-1140
    CrossrefPubMedGoogle Scholar

D. S. King,Ph. D. 

Department of Health and Human Performance, 248 Forker Building · Iowa State University

Ames · Iowa 50011 · USA

Phone: + 1 (515) 294-8429,

Fax: + 1 (515) 294-8740

Email: dsking@iastate.edu

      >